Related Experiment Video
Updated: May 6, 2026
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Targeting DUSPs in glioblastomas - wielding a double-edged sword?
Sheila Prabhakar1, Swapna Asuthkar, William Lee
1Department of Natural and Health Sciences, Southeastern University, Lakeland, Florida, 33801, USA.
Abstract:
Several dual-specificity phosphatases (DUSPs) that play key roles in the direct or indirect inactivation of different MAP kinases (MAPKs) have been implicated in human cancers over the past decade. This has led to a growing interest in identifying DUSPs and their specific inhibitors for further testing and validation as therapeutic targets in human cancers. However, the lack of understanding of the complex regulatory mechanisms and cross-talks between MAPK signaling pathways, combined with the fact that DUSPs can act as a double-edged sword in cancer progression, calls for a more careful and thorough investigation. Among the various types of brain cancer, glioblastoma multiforme (GBM) is notorious for its aggressiveness and resistance to current treatment modalities. This has led to the search for new molecular targets, particularly those involving various signaling pathways. DUSPs appear to be a promising target, but much more information on DUSP targets and their effects on GBM is needed before potential therapies can be developed, tested, and validated. This review identifies and summarize the specific roles of DUSP1, DUSP4, DUSP6 and DUSP26 that have been implicated in GBM.
Insights
Dual-specificity phosphatases (DUSPs) are crucial in cancer, but their complex roles require further study. This review focuses on specific DUSPs (DUSP1, DUSP4, DUSP6, DUSP26) and their implications in glioblastoma multiforme (GBM).
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Dual-specificity phosphatases (DUSPs) regulate mitogen-activated protein kinases (MAPKs), impacting cancer progression.
- DUSPs present a therapeutic target in oncology, yet their complex roles and pathway interactions necessitate detailed investigation.
- Glioblastoma multiforme (GBM) is an aggressive brain cancer with limited treatment options, driving the search for novel molecular targets.
Purpose of the Study:
- To review and summarize the specific roles of DUSP1, DUSP4, DUSP6, and DUSP26 in glioblastoma multiforme (GBM).
- To highlight the potential of DUSPs as therapeutic targets in GBM treatment.
Main Methods:
- Literature review of studies investigating DUSPs and their involvement in MAPK signaling pathways.
- Analysis of research implicating specific DUSPs (DUSP1, DUSP4, DUSP6, DUSP26) in glioblastoma multiforme.
Main Results:
- DUSP1, DUSP4, DUSP6, and DUSP26 have been implicated in GBM, suggesting their involvement in cancer progression.
- Understanding the specific functions of these DUSPs in GBM is critical for developing targeted therapies.
Conclusions:
- DUSPs are promising targets for glioblastoma multiforme therapy.
- Further research is essential to elucidate DUSP functions and validate them as therapeutic targets for GBM.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
